5.11 (-%)
As of Oct 02, 2024
Source:
Eliem Therapeutics, Inc is a biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems. These disorders often occur when neurons are overly excited or inhibited, leading to an imbalance, and our focus is on restoring homeostasis.
Country | United States |
Headquarters | redmond, washington |
Phone Number | 877-354-3689 |
Industry | |
CEO | Robert Azelby |
Website | www.eliemtx.com |